Transcription factor Yin Yang 1 enhances epithelial-mesenchymal transition, migration, and stemness of non-small cell lung cancer cells by targeting sonic hedgehog

被引:1
作者
Huang, Tonghai [1 ]
Ren, Kangqi [1 ]
Ling, Xiean [1 ]
Li, Zeyao [1 ]
Chen, Lin [1 ]
机构
[1] Southern Univ Sci & Technol 2, Clin Med Coll Jinan Univ,Affiliated Hosp 1, Shenzhen Peoples Hosp, Dept Thorac Surg, 1017,East Gate Rd, Shenzhen 518020, Guangdong, Peoples R China
关键词
NSCLC; YY1; Shh; EMT; Stemness; MICROENVIRONMENT;
D O I
10.1007/s11010-024-05104-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Non-small cell lung cancer (NSCLC) is a frequent type of lung cancer. Transcription factor Yin Yang 1 (YY1), an endogenous transcription factor containing zinc finger structure, can accelerate NSCLC progression. However, the impact of YY1 on the stemness of NSCLC cells and the mechanism of promoting NSCLC cell progression is unclear. YY1 and Sonic hedgehog (Shh) expressions were monitored by RT-qPCR, western blot, and immunohistochemistry. Overall survival was tested through Kaplan-Meier analysis. The interaction between YY1 and Shh was confirmed. Then, cell migration, stemness, and epithelial-mesenchymal transition (EMT) were assessed with functional experiments in vitro and in vivo. YY1 and Shh were highly expressed in NSCLC tissues and positively correlated with the poor OS of NSCLC patients. Functional experiments denoted that YY1 or Shh overexpression could accelerate EMT, migration, and stemness of NSCLC cells, and YY1 or Shh knockdown played the opposite role to its overexpression. Mechanism analysis disclosed that Shh, as a target gene of YY1, was positively related to YY1. The rescued experiment manifested that Shh silencing could reverse the induction effect of YY1 overexpression on EMT, migration, and stemness of NSCLC cells. In vivo experiments also confirmed that YY1 could accelerate tumor growth and EMT and weaken apoptosis. YY1 promotes NSCLC EMT, migration, and stemness by Shh, which might be novel diagnostic markers and therapeutic targets for NSCLC therapy.
引用
收藏
页码:1831 / 1843
页数:13
相关论文
共 50 条
[41]   Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer [J].
Nurwidya, Fariz ;
Takahashi, Fumiyuki ;
Kobayashi, Isao ;
Murakami, Akiko ;
Kato, Motoyasu ;
Minakata, Kunihiko ;
Nara, Takeshi ;
Hashimoto, Muneaki ;
Yagishita, Shigehiro ;
Baskoro, Hario ;
Hidayat, Moulid ;
Shimada, Naoko ;
Takahashi, Kazuhisa .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 455 (3-4) :332-338
[42]   ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-β [J].
Hu, Xueqian ;
Jiang, Chunqi ;
Hu, Ning ;
Hong, Shanyi .
AGING-US, 2023, 15 (06) :2097-2114
[43]   LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway [J].
Zhu, Yuanzhe ;
Wu, Huala ;
Yang, Xi ;
Xiong, Zhijuan ;
Zhao, Tiantian ;
Gan, Xin .
BIOENGINEERED, 2022, 13 (05) :13654-13666
[44]   HEDGEHOG-GLI PATHWAY INTEGRATES EPITHELIAL-MESENCHYMAL TRANSITION AND STEMNESS PROPERTIES IN PROSTATE CANCER CELLS [J].
Jiao, Min ;
Chen, Yule ;
Xu, Shan ;
Guo, Peng ;
Wang, Xinyang ;
He, Dalin ;
Zhang, Linlin .
ACTA MEDICA MEDITERRANEA, 2020, 36 (01) :385-389
[45]   Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer [J].
Yu, P. -F. ;
Kang, A. -R. ;
Jing, L. -J. ;
Wang, Y. -M. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (04) :993-1002
[46]   Low PRRX1 expression and high ZEB1 expression are significantly correlated with epithelial-mesenchymal transition and tumor angiogenesis in non-small cell lung cancer [J].
Yang, Ruixue ;
Liu, Yuanqun ;
Wang, Yufei ;
Wang, Xiaolin ;
Ci, Hongfei ;
Song, Chao ;
Wu, Shiwu .
MEDICINE, 2021, 100 (04)
[47]   Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway [J].
Da, Chunli ;
Liu, Yuting ;
Zhan, Yiyi ;
Liu, Kai ;
Wang, Ruozheng .
ONCOLOGY REPORTS, 2016, 35 (05) :2767-2774
[48]   Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells [J].
Vad-Nielsen, Johan ;
Gammelgaard, Kristine Raaby ;
Daugaard, Tina Fuglsang ;
Nielsen, Anders Lade .
LUNG CANCER, 2019, 132 :132-140
[49]   Dehydroeffusol inhibits hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway [J].
Wei, Haitao ;
Zhang, Feng ;
Wang, Jiali ;
Zhao, Min ;
Hou, Tao ;
Li, Li .
BIOSCIENCE REPORTS, 2020, 40
[50]   Inhibition of hesperidin on epithelial to mesenchymal transition of non-small cell lung cancer cells induced by TGF-β1 [J].
Yu, Hai-bin ;
Li, Li ;
Ren, Zhou-xin ;
Shen, Jun-ling .
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2016, 50 (04) :583-590